| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/04/2004 | CN1518551A Triazaspiro [5,5] undecane derivatrives and drugs containing the same as active ingredient |
| 08/04/2004 | CN1518549A Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 08/04/2004 | CN1518548A Teterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-Hydroxytryptamine-6-ligands |
| 08/04/2004 | CN1518547A Heterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 08/04/2004 | CN1518546A Selective anthranilamide pyridine amides as inhibitors of VEGRF-2 and VEGFR-3 |
| 08/04/2004 | CN1518545A Novel, ascorbic acid compounds, methods of synthesis and application use thereof |
| 08/04/2004 | CN1518543A Pyrazole derivatives and their use as protein kinase inhibitors |
| 08/04/2004 | CN1518540A Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-a, a-dimethylbenzene acetic acid and its hydrochloride |
| 08/04/2004 | CN1518463A Safety shield system for prefilled syringes |
| 08/04/2004 | CN1518461A Medicinal compositions |
| 08/04/2004 | CN1518460A Composition comprising PDE-4 inhibitor and H1-receptor antagonist and use thereof for manufacture of medicament for treatment of respiratory diseases |
| 08/04/2004 | CN1518454A Agastache rugosa extract and composition containing tilianin isolated and purified from said extract having anti-inflammatary activity and anti-atherogenic activity |
| 08/04/2004 | CN1518453A Anti-stress agents |
| 08/04/2004 | CN1518450A Use of adenosine analogues for treatment of insulin resisttance syndrome and diabetes |
| 08/04/2004 | CN1518448A Antihistamines for treatment of nasal congestion and nasal obstruction |
| 08/04/2004 | CN1518447A Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 08/04/2004 | CN1518443A Stable pharmaceutical composition of pravastatin |
| 08/04/2004 | CN1518441A Particles for inhalation having rapid release properties |
| 08/04/2004 | CN1517342A Chinese torreya taxadol treatment method used for anticancer and antisanility |
| 08/04/2004 | CN1160457C Recombinant mistletoe lectin (rML) |
| 08/04/2004 | CN1160368C Endothelin antegon |
| 08/04/2004 | CN1160360C Oxazonaphthalone compounds for enhancing synaptic response |
| 08/04/2004 | CN1160357C Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl acetic acid |
| 08/04/2004 | CN1160356C Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 08/04/2004 | CN1160355C Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof |
| 08/04/2004 | CN1160348C Aryl-{4-fluoro-4-{(2-pyridin-2-YL-ethylamino)-methyl]-piperidin-yl}-methanone derivatives as 5-HT1 receptor antagonists |
| 08/04/2004 | CN1160344C Compounds for treatment of asthma, allergy and inflammatory disorders and its use |
| 08/04/2004 | CN1160343C Aminothiazole inhibitors of cyclin dependent protein kinasses of cells |
| 08/04/2004 | CN1160338C N-[4-(3-chloro-4-fluoro-phenylamino)-7-(-3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, irreversible inihibotr of tyrosine kinases |
| 08/04/2004 | CN1160331C Process for preparing photoactivated (-) yellow skin amide |
| 08/04/2004 | CN1160330C N-substituted 2-cyanopyrrolidines compound |
| 08/04/2004 | CN1160312C Substituted alkyl tetramine dervative |
| 08/04/2004 | CN1160309C Alkyloxyamino substitued fluorenones and their use as protein kinase C inhibitors |
| 08/04/2004 | CN1160121C Growth hormone liposome for pig and its preparation method |
| 08/04/2004 | CN1160103C Medicine for treating ADHD (Attentional Deficit Hyperactivity Disorder) |
| 08/04/2004 | CN1160095C Antisanility health-care cream and its preparing process |
| 08/04/2004 | CN1160092C Ointment with relax the muscles and stimulate the blood circulation function and its preparation method |
| 08/04/2004 | CN1160081C Combination therapy of HIV infection using HIV protease inhibitior induinavir and reverse transcriptase inhibitor 3TC, optionally together with AZT, DDI or DDC |
| 08/04/2004 | CN1160080C Use of algin oligosaccharide for preparing medicine for preventing dementia by hyoscine |
| 08/04/2004 | CN1160078C sialic acid, its salt, pharmaceutical use of its polymer or salt of polymer |
| 08/04/2004 | CN1160068C Inihibition of lipoprotein oxidation |
| 08/04/2004 | CN1160065C Use of preparing medicine for treating depression by low affinity NMDA antagonists |
| 08/04/2004 | CN1160053C Niacinamide compsns. with reduced tack |
| 08/04/2004 | CN1159984C Prophylactic dietary supplement based on milk |
| 08/03/2004 | US6770778 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 08/03/2004 | US6770746 Chemical modification of proteins to improve biocompatibility and bioactivity |
| 08/03/2004 | US6770742 Use of inhibitors for the treatment of disorders related to RTK hyperfunction, especially cancer |
| 08/03/2004 | US6770678 Warming (methylsulfonyl substituted-)-benzoylguanidine salt solution to accelerate dissolution; filtration, high speed freeze drying |
| 08/03/2004 | US6770676 Dicarboxylic acid derivatives |
| 08/03/2004 | US6770669 Amidine derivatives, preparation and use thereof as medicines |
| 08/03/2004 | US6770661 Aryl substituted pyridines and their use |
| 08/03/2004 | US6770656 Amine derivatives for the treatment of apoptosis |
| 08/03/2004 | US6770654 Indole derivatives and use thereof in medicines |
| 08/03/2004 | US6770653 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin |
| 08/03/2004 | US6770651 A2B adenosine receptor antagonists |
| 08/03/2004 | US6770649 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them |
| 08/03/2004 | US6770644 Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient |
| 08/03/2004 | US6770643 Inhibit protein kinases |
| 08/03/2004 | US6770642 For use in treatment of cns disorders such as anxiety, depression, epilepsy, obsessive compulsive disorder, attention deficit disorder, migraine, cognitive memory enhancement, alzheimer's disease |
| 08/03/2004 | US6770637 Substituted 4-phenyl-pyridine compounds with activity as antagonists of neurokinin 1 receptors |
| 08/03/2004 | US6770631 Non-identical genes and their application in improved molecular adjuvants |
| 08/03/2004 | US6770629 Polymerase inhibitor; anticancer agent |
| 08/03/2004 | US6770628 Hematopoietic stimulation |
| 08/03/2004 | US6770619 Lung surfactant compositions with dynamic swelling behavior |
| 08/03/2004 | US6770307 Plant extract for diabetic therapy |
| 08/03/2004 | US6770267 Methods of treating periodontal disease |
| 08/03/2004 | CA2270386C Process for substituted pyridines |
| 08/03/2004 | CA2136836C Piperidinyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension |
| 08/03/2004 | CA2110161C Medetomidine preparations for transdermal administration |
| 08/03/2004 | CA2089111C Smooth muscle mitogen and isolated dna coding therefor |
| 08/03/2004 | CA2058768C Treatment and control of ocular development |
| 08/03/2004 | CA2041093C A pharmacological composition containing polyelectrolyte complexes in microparticulate form and at least one active substance |
| 07/29/2004 | WO2004063748A1 Method of screening agonist or antagonist to thyroxine receptor |
| 07/29/2004 | WO2004063221A1 Metastin derivative and use thereof |
| 07/29/2004 | WO2004063202A1 Fused furan compound |
| 07/29/2004 | WO2004063201A1 Therapeutic agent for schizophrenia |
| 07/29/2004 | WO2004063167A1 Blood-brain barrier disruption inhibitors |
| 07/29/2004 | WO2004062693A1 Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene theraphy |
| 07/29/2004 | WO2004062691A1 Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same |
| 07/29/2004 | WO2004062657A1 Acylated 4-amidino- and 4-guanidinobenzylamines for the inhibition of plasma kallikrein |
| 07/29/2004 | WO2004062606A2 Method of achieving accelerated fat loss by administration of a fat loss accelerating agent to a dieting mammal |
| 07/29/2004 | WO2004062592A2 2-o sulfatase compositions and related methods |
| 07/29/2004 | WO2004062555A2 Use of natriuretic peptides for the treatment of stature disorders related to the shox gene |
| 07/29/2004 | WO2004045533A3 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/29/2004 | WO2004037173A3 Method for treating erectile dysfunction and increasing libido in men |
| 07/29/2004 | WO2004035574A8 Substituted aminoquinuclidine compounds and their use as delta-opioid receptor ligands |
| 07/29/2004 | WO2004035536A3 Azo compounds for type i phototherapy |
| 07/29/2004 | WO2004026816B1 Aromatic liver x-receptor modulators |
| 07/29/2004 | WO2004014913A3 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
| 07/29/2004 | WO2004010972A3 Pellicle-resistant gelatin capsule |
| 07/29/2004 | WO2003101382A3 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 07/29/2004 | WO2003099783A3 Tropane compounds |
| 07/29/2004 | WO2003094850A3 Lipid a and other carbohydrate ligand analogs |
| 07/29/2004 | WO2003093313A3 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein |
| 07/29/2004 | WO2003075741A3 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 07/29/2004 | WO2003070881A3 RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN TYPROSINE PHOSPHATASE-1B (PTP-1B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/29/2004 | WO2003068803A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/29/2004 | WO2003059355A8 Quinazolinone compounds in combined modalities for improved cancer treatment |
| 07/29/2004 | WO2003028634A8 Method of treatment using ligand-immunogen conjugates |
| 07/29/2004 | WO2003003941A3 One dose vaccination with mycoplasma hyopneumoniae |